← Leaderboards
Mitchell Isaac Parker
Drexel University
$190,725
Attributed
$190,725
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $57.7K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$190,725 · 1
By mechanism
F30$190,725 · 1
Top collaborators
No co-investigators on record.
Most similar at Drexel University
Same institution · by research overlap
- Eishi Noguchi$1,628,508
- Cameron F Abrams$6,331,501
- Spiros Mancoridis$334,543
- Harish Sethu$1,206,238
- Jeffrey L Popyack$892,950
Others in their field
Other Emerging Leaders on “Experimental Study”
- John Hobbs · Suny At Stony Brook$42,194,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Christopher Bee · Suny At Stony Brook$41,239,084
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,024,342
- John Damon Chodera · Sloan-Kettering Inst Can Research$18,835,102
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
Research focus
Experimental StudyAlanine3-DimensionalAgreementBehaviorBindingBiochemicalAntibodiesCanadaCancer TherapyClassificationCohortComplexComputational SuiteComputerized ToolsComputer SoftwareConformerBiologicalDatabasesDesignElectron DensityEuropeEventFuture
Grant awards (5)
Creating a Unified RAS Structural Nomenclature to Compare the Impact of Oncogenic Mutations on KRAS, NRAS, and HRAS$40,487
F30 · FY2024 · GM · contact PI
Creating a Unified RAS Structural Nomenclature to Compare the Impact of Oncogenic Mutations on KRAS, NRAS, and HRAS$55,194
F30 · FY2023 · GM · contact PI
Creating a Unified RAS Structural Nomenclature to Compare the Impact of Oncogenic Mutations on KRAS, NRAS, and HRAS$2,500
F30 · FY2023 · GM · contact PI
Creating a Unified RAS Structural Nomenclature to Compare the Impact of Oncogenic Mutations on KRAS, NRAS, and HRAS$46,630
F30 · FY2022 · GM · contact PI
Creating a Unified RAS Structural Nomenclature to Compare the Impact of Oncogenic Mutations on KRAS, NRAS, and HRAS$45,914
F30 · FY2021 · GM · contact PI